JAB-BX102

· Jacobio Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for JAB-BX102, covering 2026-01-06 to 2026-01-06. Get the full timeline:

Most recent: Clinical Trial Update: JAB-BX102 Monotherapy and Combination With Pembrolizumab in Adult Patients With Advanced Solid Tumors [Phase 1, Phase 2]

See pricing